These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18413389)

  • 1. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
    Kumar SR; Deutscher SL
    J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting and SPECT imaging properties of an (111)In-labeled galectin-3 binding peptide in prostate carcinoma.
    Deutscher SL; Figueroa SD; Kumar SR
    Nucl Med Biol; 2009 Feb; 36(2):137-46. PubMed ID: 19217525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
    Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
    Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas.
    Kumar SR; Quinn TP; Deutscher SL
    Clin Cancer Res; 2007 Oct; 13(20):6070-9. PubMed ID: 17947470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
    Kumar SR; Gallazzi FA; Quinn TP; Deutscher SL
    J Nucl Med; 2011 Nov; 52(11):1819-26. PubMed ID: 21984800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.
    Jiang L; Kimura RH; Miao Z; Silverman AP; Ren G; Liu H; Li P; Gambhir SS; Cochran JR; Cheng Z
    J Nucl Med; 2010 Feb; 51(2):251-258. PubMed ID: 20124048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomas.
    Deutscher SL; Figueroa SD; Kumar SR
    J Labelled Comp Radiopharm; 2009 Dec; 52(14):583-590. PubMed ID: 20976123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.
    Larimer BM; Thomas WD; Smith GP; Deutscher SL
    Mol Imaging Biol; 2014 Aug; 16(4):449-58. PubMed ID: 24550054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting.
    Nock BA; Maina T; Krenning EP; de Jong M
    J Nucl Med; 2014 Jan; 55(1):121-7. PubMed ID: 24287321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.
    Roosenburg S; Laverman P; Joosten L; Cooper MS; Kolenc-Peitl PK; Foster JM; Hudson C; Leyton J; Burnet J; Oyen WJ; Blower PJ; Mather SJ; Boerman OC; Sosabowski JK
    Mol Pharm; 2014 Nov; 11(11):3930-7. PubMed ID: 24992368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo targeting of HER2-positive tumor using 2-helix affibody molecules.
    Ren G; Webster JM; Liu Z; Zhang R; Miao Z; Liu H; Gambhir SS; Syud FA; Cheng Z
    Amino Acids; 2012 Jul; 43(1):405-13. PubMed ID: 21984380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of chelate conjugation on a newly identified tumor-targeting peptide.
    Mier W; Zitzmann S; Krämer S; Reed J; Knapp EM; Altmann A; Eisenhut M; Haberkorn U
    J Nucl Med; 2007 Sep; 48(9):1545-52. PubMed ID: 17704241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
    Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M
    J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake.
    Guo H; Yang J; Gallazzi F; Miao Y
    J Nucl Med; 2010 Mar; 51(3):418-26. PubMed ID: 20150256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591.
    Tolmachev V; Varasteh Z; Honarvar H; Hosseinimehr SJ; Eriksson O; Jonasson P; Frejd FY; Abrahmsen L; Orlova A
    J Nucl Med; 2014 Feb; 55(2):294-300. PubMed ID: 24408895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
    Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
    J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 111In-labeled cystine-knot peptides based on the Agouti-related protein for targeting tumor angiogenesis.
    Jiang L; Miao Z; Kimura RH; Silverman AP; Ren G; Liu H; Lu H; Cochran JR; Cheng Z
    J Biomed Biotechnol; 2012; 2012():368075. PubMed ID: 22570527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.
    Kumar P; Tripathi SK; Chen CP; Wickstrom E; Thakur ML
    Mol Imaging Biol; 2019 Feb; 21(1):130-139. PubMed ID: 29802552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice.
    Lo WL; Lo SW; Chen SJ; Chen MW; Huang YR; Chen LC; Chang CH; Li MH
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.